呼吸器内科医,
ファセンラの長期安全性に関する臨床試験です。 「SIROCCO試験あるいはCALIMA試験における633人がベンラリズマブ4週ごと、639人がベンラリズマブ8週ごとに割り付けられた。残る654人はこれらの研究でプラセボ群であり、再度ランダムにベンラリズマブ…
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
Overview of attention for article published in The Lancet Respiratory Medicine, November 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Mentioned by
- news
- 2 news outlets
- 8 X users
- 1 Facebook page
- guideline
- 5 clinical guideline sources
Readers on
- mendeley
- 267 Mendeley